drugset / Trial / NCT03220542

The Effect of Broccoli Sprout Extract and Probiotics for Eradication of Helicobacter Pylori

NCT03220542

Phase 4 Unknown 360 enrolled Kyunghee University Medical Center
RandomizedFactorialSingle-blindTreatment

Summary

In Korea, the first-line therapy to treat Helicobacter pylori (Hp) consists of a proton pump inhibitor (PPI) and two antibiotics for one week. But, eradication has become less successful due to low compliance and high resistance to the antibiotics. Therefore, it is necessary to develop new treatment strategies that increase the eradication rate and reduce adverse effects. In vitro study, we previously reported that a broccoli sprout extract containing sulforaphane may prevent lipid peroxidation in the gastric mucosa and play a cytoprotective role in Hp-induced gastritis. Also, several studies suggested that probiotics could be effective for improving Hp eradication rate or reducing adverse events. But, their effect for eradication of Hp is not yet conclusive. The aims of this prospective study is to investigate the efficacy of a broccoli sprout extract containing sulforaphane and probiotics for eradication of Hp, compared with standard triple therapy.

Timeline

Start
2016-01
Primary completion
2018-12-31
Completion
2019-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Saccharomyces boulardii Other / unclassified
Background Amoxicillin Other / unclassified
Background Clarithromycin Small molecule
Background Esomeprazole Small molecule